SCHEMBL27344784

SCHEMBL27344784

C/C(=N\NS(=O)(=O)c1ccc(C)cc1)c1ccc2c(c1)Nc1cc(F)ccc1O2

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.55
PDE3A Q14432 1/20 0.55
ALDH1A1 P00352 8/20 0.48
KDM4E B2RXH2 1/20 0.48
KMT2A Q03164 6/20 0.48
MEN1 O00255 5/20 0.47
GAA P10253 3/20 0.47
LMNA P02545 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
HTT P42858 1/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
XDH P47989 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30811582 1.00 PDE3B (0.55) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL27344603 0.88 PDE3B (0.56) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL27346252 0.88 PDE3B (0.55) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL27346225 0.87 PDE3B (0.52) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL27346243 0.85 PDE3B (0.55) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL30811584 0.85 PDE3B (0.55) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL27344605 0.84 PDE3B (0.52) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL27346269 0.82 PDE3B (0.50) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL30811542 0.81 PDE3B (0.50) PDE3BPDE3AALDH1A1KDM4EKMT2A
SCHEMBL27344794 0.81 PDE3B (0.50) PDE3BPDE3AALDH1A1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023245297-A1 FERROPTOSIS INHIBITORS AND USES THEREOF UNIVERSITY OF OTTAWA (CA) 2023-12-28 WO disclosed